schizophrenia

News and resources

Month: July 2025

Jul 12 2025

Treatments for Schizophrenia with Accordia Health’s Dr. Evan Chavers and Dr. Shyla Hossain

by Clinical Editor

No Comments

Dr. Evan Chavers and Dr. Shyla Hossain from Accordia Health joined WKRG News 5’s The Doctor is In to discuss schizophrenia and available treatment options. In the video …

Jul 12 2025

AZ man’s death on hot pavement was due to negligence, lawsuit claims

by Clinical Editor

No Comments

LaFayette Palmes was found dead on the pavement in July 2024 with a body temperature of almost 110 degrees, according to the suit.

Jul 11 2025

Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data – Yahoo Finance

by Clinical Editor

No Comments

Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data Yahoo Finance

Jul 11 2025

Why Long-Acting Injectables Deserve Our Attention in Schizophrenia Care – HCPLive

by Clinical Editor

No Comments

Why Long-Acting Injectables Deserve Our Attention in Schizophrenia Care HCPLive

Jul 10 2025

Sister managed schizophrenia for years, until AI said diagnosis was wrong – Newsweek

by Clinical Editor

No Comments

Sister managed schizophrenia for years, until AI said diagnosis was wrong Newsweek

Jul 10 2025

J&J defeats generic drugmakers in US appeal over schizophrenia treatment

by Clinical Editor

No Comments

Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to invalidate a patent covering its schizophrenia medication Invega Sustenna.

Jul 09 2025

New research suggests similar brain patterns in seizure-linked psychosis and schizophrenia

by Clinical Editor

No Comments

Latest research at the Epilepsy Society using pioneering research equipment has shown parallels between people with seizure-linked.

Jul 09 2025

Johnson & Johnson submits sNDA to US FDA for Caplyta for prevention of relapse in schizophrenia

by Clinical Editor

No Comments

Johnson & Johnson submits sNDA to US FDA for Caplyta for prevention of relapse in schizophrenia: Titusville, New Jersey Wednesday, July 9, 2025, 14:00 Hrs [IST] Johnson & Johnson …

Jul 08 2025

Relationship between grammar and schizophrenia: a systematic review and meta-analysis – Nature

by Clinical Editor

No Comments

Relationship between grammar and schizophrenia: a systematic review and meta-analysis Nature

Jul 08 2025

Dealing With the Devastation of a Schizophrenia Diagnosis

by Clinical Editor

No Comments

Receiving a schizophrenia diagnosis can be devastating. Many are unaware they are sick, refusing medication, temporarily unable to work, and disjointed from friends.